Filing Details
- Accession Number:
- 0001062993-25-009985
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-21 16:13:14
- Reporting Period:
- 2025-05-20
- Filing Date:
- 2025-05-21
- Accepted Time:
- 2025-05-21 16:13:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1533040 | Phio Pharmaceuticals Corp. | PHIO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1792987 | L Robert Ferrara | C/O Phio Pharmaceuticals Corp. 11 Apex Dr., Suite 300A, Pmb 2006 Marlborough MA 01752 | Yes | No | No | No |
Transaction Summary
| Purchased: | 2,500 shares | Avg. Price: $1.82 | Total Value: $4,550.00 |
| Number of Shares After Transactions: | 13,166 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Acquisiton | 2025-05-20 | 2,500 | $1.82 | 13,166 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at $1.82. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the transactions.
- Includes shares of common stock underlying unvested restricted stock units.
- The number of reported securities has been adjusted to reflect prior reverse stock splits.
Billionaire Hedge Funds
